Free Trial
→ Trump won. Buy this coin now. (From Weiss Ratings) (Ad) Free CTMX Stock Alerts

CytomX Therapeutics (CTMX) ESG Score & Sustainability Data

CytomX Therapeutics logo
$0.89 +0.02 (+2.30%)
(As of 11/22/2024 ET)
Compare

Key ESG Takeaways for CytomX Therapeutics

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of CytomX Therapeutics. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • CytomX Therapeutics seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Preclinical research services for physical health, Basic medical research services, and Clinical research services for cancer products.
  • CytomX Therapeutics uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for cancer, Preclinical research services for physical health, and Basic medical research services products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, CytomX Therapeutics would improve its net impact ratio by 0 percentage points.

CTMX Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.2%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+77.8%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+70.7%
Society First
Value set that emphasizes society impacts over other impacts.
+51.5%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+89.5%
Health First
Value set that emphasizes health impacts over other impacts.
+85.9%

CytomX Therapeutics ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.27
+1.27
+1.64
+1.64
+0.00
+0.00
-0.01
-0.01
+0.00
-0.00
+0.22
+0.22
+0.00
+0.00
+3.83
+3.83
-0.00
+0.00
+0.00
-1.88
-1.88
-0.26
+3.47
+3.73
-0.03
+0.43
+0.46
0.00
+0.00
-0.00
+0.00
+0.01
-0.00
+0.17
+0.17
-0.41
-0.41
+0.00
-0.02
-0.02
+0.00
-0.01
-0.01
+0.00
-0.01
-0.01
+0.00
-0.28
-0.28
+0.00

Upright Model Version 0.7.0
ESG Data Last Updated: December 8, 2022

Ad Insiders Exposed
917 Trades… Zero Losses?
As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”
Go here to see how you can start accessing these opportunities today

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

CytomX Therapeutics ESG Score - Frequently Asked Questions

How is CytomX Therapeutics doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, CytomX Therapeutics has a net impact ratio of 74.2%, indicating an overall positive sustainability impact. CytomX Therapeutics seems to create the most significant positive value in the categories of Creating knowledge, Physical diseases, and Taxes. CytomX Therapeutics uses resources or causes negative impacts mostly in the categories of Scarce human capital, GHG emissions, and Waste. Learn more on the sustainability of CytomX Therapeutics.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:CTMX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
But another coin could soar even higher …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...
Weiss Ratings | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...
Crypto Swap Profits | Sponsored